IMIGRANE 6 mg/0.5 ml, solution for injection for subcutaneous use in a pre-filled syringe 2 syringes of 0.5 ml, CIP 3400933387457
Active ingredients: Sumatriptan succinate, Sumatriptan
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection2 syringes of 0.5 ml, CIP 3400933387457sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- IMIGRANE 6 mg/0,5 ml, solution injectable pour voie sous-cutanée en seringue pré-remplie
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 2 seringue(s) préremplie(s) en verre de 0,5 ml
- Marketing authorisation holder
- GLAXOSMITHKLINE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 19 Sept 1994
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69485328CIP73338745CIP133400933387457Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SUCCINATE DE SUMATRIPTANsolution | 8,4 mg · une seringue pré-remplie | SA |
| SUMATRIPTANsolution | 6,0 mg · une seringue pré-remplie | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.